JP7614092B2 - ミトコンドリア標的化ペプチド - Google Patents

ミトコンドリア標的化ペプチド Download PDF

Info

Publication number
JP7614092B2
JP7614092B2 JP2021533219A JP2021533219A JP7614092B2 JP 7614092 B2 JP7614092 B2 JP 7614092B2 JP 2021533219 A JP2021533219 A JP 2021533219A JP 2021533219 A JP2021533219 A JP 2021533219A JP 7614092 B2 JP7614092 B2 JP 7614092B2
Authority
JP
Japan
Prior art keywords
amino
mmol
amino acid
synthesis
ischemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021533219A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022511939A (ja
JP2022511939A5 (cg-RX-API-DMAC7.html
Inventor
ヂォン,グオヂュー
ジェイ バンバーガー,マーク
スムクステ,イネセ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stealth Biotherapeutics Inc
Original Assignee
Stealth Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stealth Biotherapeutics Inc filed Critical Stealth Biotherapeutics Inc
Publication of JP2022511939A publication Critical patent/JP2022511939A/ja
Publication of JP2022511939A5 publication Critical patent/JP2022511939A5/ja
Application granted granted Critical
Publication of JP7614092B2 publication Critical patent/JP7614092B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2021533219A 2018-12-18 2019-11-19 ミトコンドリア標的化ペプチド Active JP7614092B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862781153P 2018-12-18 2018-12-18
US62/781,153 2018-12-18
US201962892939P 2019-08-28 2019-08-28
US62/892,939 2019-08-28
PCT/US2019/062283 WO2020131282A1 (en) 2018-12-18 2019-11-19 Mitochondria-targeting peptides

Publications (3)

Publication Number Publication Date
JP2022511939A JP2022511939A (ja) 2022-02-01
JP2022511939A5 JP2022511939A5 (cg-RX-API-DMAC7.html) 2022-11-21
JP7614092B2 true JP7614092B2 (ja) 2025-01-15

Family

ID=71101606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021533219A Active JP7614092B2 (ja) 2018-12-18 2019-11-19 ミトコンドリア標的化ペプチド

Country Status (8)

Country Link
US (2) US12404300B2 (cg-RX-API-DMAC7.html)
EP (1) EP3898652A4 (cg-RX-API-DMAC7.html)
JP (1) JP7614092B2 (cg-RX-API-DMAC7.html)
CN (1) CN113544138B (cg-RX-API-DMAC7.html)
AU (1) AU2019403856B2 (cg-RX-API-DMAC7.html)
CA (1) CA3123368A1 (cg-RX-API-DMAC7.html)
IL (2) IL284006B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020131282A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11332499B2 (en) 2018-08-16 2022-05-17 Regents Of The University Of Minnesota Cyclic peptides and methods of use thereof
CN113544138B (zh) 2018-12-18 2024-10-29 隐形生物治疗公司 线粒体靶向肽
WO2020131283A1 (en) 2018-12-18 2020-06-25 Stealth Biotherapeutics Corp. Analogs that target mitochondrial diseases
CN118955233B (zh) * 2024-07-27 2025-05-06 康龙化成手性医药技术(宁波)有限公司 一种单取代双环[1.1.1]戊烷(bcp)的合成方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516652A (ja) 2003-02-04 2006-07-06 コーネル リサーチ ファウンデイション インコーポレイテッド ミトコンドリア透過性転移の阻止方法
JP2013522311A (ja) 2010-03-15 2013-06-13 ステルス ペプチドズ インターナショナル インコーポレイテッド シクロスポリンおよび芳香族カチオン性ペプチドを用いた併用療法
JP2013531682A (ja) 2010-07-09 2013-08-08 ステルス ペプチドズ インターナショナル インコーポレイテッド 虚血/再灌流障害に続くノーリフローの予防又は処置方法
JP2014518213A (ja) 2011-06-14 2014-07-28 ステルス ペプチドズ インターナショナル インコーポレイテッド 芳香族カチオン性ペプチド及びその使用
WO2017093897A1 (en) 2015-11-30 2017-06-08 Peter Schiller Aromatic-cationic peptides conjugated to antioxidants and their use in treating complex regional pain syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2606022A2 (en) * 2010-08-16 2013-06-26 Santhera Pharmaceuticals (Schweiz) AG Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function
US8383919B2 (en) * 2010-12-14 2013-02-26 Xueyun Gao Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof
CA2858550A1 (en) * 2011-12-09 2013-06-13 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CA2865409C (en) * 2012-02-23 2020-07-21 Cornell University Aromatic-cationic peptides and uses of same
US10870678B2 (en) * 2016-04-11 2020-12-22 Arcuate Therapeutics, Inc. Chiral peptides
CN113544138B (zh) 2018-12-18 2024-10-29 隐形生物治疗公司 线粒体靶向肽
WO2020131283A1 (en) 2018-12-18 2020-06-25 Stealth Biotherapeutics Corp. Analogs that target mitochondrial diseases

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516652A (ja) 2003-02-04 2006-07-06 コーネル リサーチ ファウンデイション インコーポレイテッド ミトコンドリア透過性転移の阻止方法
JP2013522311A (ja) 2010-03-15 2013-06-13 ステルス ペプチドズ インターナショナル インコーポレイテッド シクロスポリンおよび芳香族カチオン性ペプチドを用いた併用療法
JP2013531682A (ja) 2010-07-09 2013-08-08 ステルス ペプチドズ インターナショナル インコーポレイテッド 虚血/再灌流障害に続くノーリフローの予防又は処置方法
JP2014518213A (ja) 2011-06-14 2014-07-28 ステルス ペプチドズ インターナショナル インコーポレイテッド 芳香族カチオン性ペプチド及びその使用
WO2017093897A1 (en) 2015-11-30 2017-06-08 Peter Schiller Aromatic-cationic peptides conjugated to antioxidants and their use in treating complex regional pain syndrome

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Cardiovascular Drugs Therapy,2016年,Vol.30, No.6,pp.559-566

Also Published As

Publication number Publication date
JP2022511939A (ja) 2022-02-01
IL314309B1 (en) 2025-05-01
US20260055136A1 (en) 2026-02-26
CA3123368A1 (en) 2020-06-25
IL284006A (en) 2021-08-31
EP3898652A4 (en) 2022-08-24
IL284006B1 (en) 2024-08-01
CN113544138A (zh) 2021-10-22
US12404300B2 (en) 2025-09-02
KR20210093957A (ko) 2021-07-28
IL284006B2 (en) 2024-12-01
US20220041653A1 (en) 2022-02-10
AU2019403856A1 (en) 2021-06-24
IL314309B2 (en) 2025-09-01
EP3898652A1 (en) 2021-10-27
IL314309A (en) 2024-09-01
AU2019403856B2 (en) 2025-05-01
CN113544138B (zh) 2024-10-29
WO2020131282A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
JP7576670B2 (ja) ミトコンドリア標的化ペプチド
US20260055136A1 (en) Mitochondria-targeting peptides
JP7606966B2 (ja) ミトコンドリア病を標的とするアナログ
AU2020260489A1 (en) Chiral peptides
EP4168423A1 (en) Prodrugs of mitochodria-targeting oligopeptides
US20240059734A1 (en) Mitochondria-targeting peptides
WO2021262708A1 (en) Prodrugs of mitochodria-targeting oligopeptides
CA3085772C (en) Mitochondria-targeting peptides
HK40116853A (en) Mitochondria-targeting peptides
HK40039982A (en) Mitochondria-targeting peptides
HK40107199A (zh) 线粒体靶向肽
HK40097183A (en) Mitochondria-targeting peptides
HK40039982B (en) Mitochondria-targeting peptides
HK40035078A (en) Mitochondria-targeting peptides
HK40035078B (en) Mitochondria-targeting peptides

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20220111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230921

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240221

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240927

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20241008

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241216

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241226

R150 Certificate of patent or registration of utility model

Ref document number: 7614092

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150